You Searched For "Novartis" and got 20 results
Sort By:
2 mins read
Novartis India shares jump more than 6% after parent company announces strategic review
Novartis India shares jumped more than 6 per cent on Monday after the parent company, Novartis AG a…
3 mins read
Novartis debuted its first integrated sustainability and finance report this year — more companies are likely to follow suit
The global pharmaceutical company, Novartis, released its first-ever integrated social impact repor…
Julia Hood
1 min read
Digital hub ''Novartis Biome India'' launched in Hyderabad
Claimed to be the first in Asia, the 'Novartis BiomeIndia' is aimed at boosting connection and inte…
PTI
2 mins read
SAP Labs offer the best salaries in India and Cisco the best work-life balance, says survey
German software multinational SAP Labs has been ranked as the top ‘new-age employer’ in India — tha…
2 mins read
Mylan, Dr Reddy's, Aurobindo, and Torrent Pharma can't sell generic Gilenya that is patented by Novartis
A US court has ordered generic drug makers including Mylan, Dr Reddy's Laboratories, Aurobindo Ph…
1 min read
Novartis India Q3 net profit declines 40 pc to Rs 8 cr
Revenue from operations of the company stood at Rs 117.46 crore for the quarter under consideratio…
PTI
1 min read
Novartis CEO said he was 'completely blindsided' by Michael Cohen contract
Novartis changed CEOs in February, with Narasimhan replacing former CEO Joe Jimenez. Narasimhan was…
Lydia Ramsey
4 mins read
Dispensed: Oscar's first moves in Medicare Advantage, uBiome's new board members, and Novartis' CEO's commitment to wearing jeans
Something to keep an eye out for going into the end of July - the Livongo IPO is upon us. On Monday…
Lydia Ramsey
4 mins read
Novartis just laid out the playbook for making its $2.1 million gene therapy treatment a blockbuster. Here are the next steps.
Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…
Andrew Dunn
6 mins read
Microsoft just forged a key alliance with the Swiss pharma giant Novartis to win a bigger piece of an $11 billion market
The first is using AI for exploration, seeing whether researchers can sift through Novartis' resear…
Lydia Ramsey
5 mins read
Novartis, one of the world's largest drugmakers, is turning to AI and data science to reinvent its business - and it's become Microsoft's shining example of 'tech intensity'
Bodson, formerly the chief digital officer of British retailer Sainsburys' Argos and a senior group…
Ashley Stewart
5 mins read
Dispensed: Amazon and Best Buy's expanding healthcare ambitions, the history of controversial e-cig startup Juul, and the lowdown on Novartis' letter to the FDA
Over the past few weeks, it's been worrisome to watch as the number of deaths connected with vaping…
Lydia Ramsey
2 mins read
Cancer-therapy provider Endocyte spikes 50% after Novartis agrees to buy it for $2.1 billion
"We are thrilled that Novartis recognizes the potential for 177Lu-PSMA-617 to change the treatment …
Ethel Jiang
4 mins read
Indian pharma sector is going through an interesting phase with Novartis being the latest
The stand-alone total income from operations of the company declined 4.4% to Rs 224.43 crore during…
2 mins read
Pharmaceutical companies like Novartis and Lilly are starting to pick up cues from Silicon Valley
The healthcare artificial intelligence market is projected to grow exponentially in the coming dec…
Charlotte Hu
3 mins read
A top Novartis executive says the $225 billion drug giant is planning for a 'doomsday scenario' in cancer treatment
Jay Bradner heads up Novartis's drug research and discovery, as president of the Novartis Institute…
Emma Court,Matt Turner
3 mins read
A new Senate report says that Novartis had more contact with Michael Cohen than it let on
"We disagree with the report's conclusion that we issued a misleading public statement regarding th…
Lydia Ramsey
3 mins read
The CEO of Swiss pharma giant Novartis voluntarily gave up $400,000 of his bonus, thanks to a controversy swirling around the world's most expensive drug
In applying for approval, Novartis submitted manipulated mice testing data to US regulators, the US…
Andrew Dunn
6 mins read
Pharma giants like Novartis and Sanofi are betting that the future of healthcare looks more like an app or sensor than a prescription
Another reason for the rise of digital treatments is that drugs just aren't cutting it anymore. We'…
Lydia Ramsey
2 mins read
Drug giant Novartis is going after a $5 billion eye-drug market
In data presented Friday at the American Academy of Opthamology annual conference, Novartis' drug b…